PRTA
Prothena Corporation plc
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Sell
-44/100
Last price
8.16
▼ 0.11 (1.33%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
8.28
Prev close
8.27
Day high
8.28
Day low
7.80
Volume
509.61K
Market cap
$411.72M
P/E (TTM)
—
52W range
7.73 – 11.80
Day trading desk
Gap from prior close
+0.12%
Prior close 8.27
VWAP
8.02
+1.75% from price
Relative volume
1.92×
Unusually busy
Session range
6.15%
7.80 – 8.28
Position in range
75%
Near session high
ATR (14D)
0.41
5.05% of price
Prior day high
8.37
PDH
Prior day low
7.91
PDL
Bid / ask spread
—
Quote not published
Session volume
917.36K
Avg 477.69K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-8.66%
-10.6%
1M
-18.33%
-19.5%
3M
-18.58%
-23.1%
6M
-22.59%
-40.8%
YTD
-16.02%
-30.3%
1Y
-19.15%
-35.6%
3Y
-83.38%
-165.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PRTA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+2.10M
Net buying
Buy transactions
19
2.11M shares
Sell transactions
2
16.05K shares
Net transactions
+21
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
11.47M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 29, 26 | SCULLY WILLIAM P Beneficial Owner of more than 10% of a Class of Security |
BUY | 162.00K | $1.41M | Indirect |
| Sep 28, 26 | SCULLY WILLIAM P Beneficial Owner of more than 10% of a Class of Security |
BUY | 103.50K | $889.87K | Indirect |
| Sep 18, 26 | SCULLY WILLIAM P Beneficial Owner of more than 10% of a Class of Security |
BUY | 100.00K | $843.46K | Direct |
| Sep 2, 26 | SCULLY WILLIAM P Beneficial Owner of more than 10% of a Class of Security |
BUY | 27.00K | $255.74K | Direct |
| Aug 20, 26 | SCULLY WILLIAM P Beneficial Owner of more than 10% of a Class of Security |
BUY | 50.00K | $439.43K | Direct |
| Aug 18, 26 | SCULLY WILLIAM P Beneficial Owner of more than 10% of a Class of Security |
STOCK | 627.55K | $0 | Direct |
| Aug 7, 26 | SCULLY WILLIAM P Beneficial Owner of more than 10% of a Class of Security |
BUY | 37.50K | $323.22K | |
| Jul 29, 26 | KINGSTON ANNE EVANS Officer |
SELL | 7.66K | $64.92K | Direct |
| Jul 29, 26 | ISAACS MICHAEL JOHN General Counsel |
SELL | 8.39K | $71.06K | Direct |
| Jul 28, 26 | WALKER KARIN LORRAINE Officer |
— | 15.00K | — | Direct |
| Jul 28, 26 | NGUYEN TRAN BRYAN Chief Financial Officer |
— | 57.00K | — | Direct |
| Jul 28, 26 | KINNEY GENE G PH.D. Chief Executive Officer |
— | 84.00K | — | Direct |
| Jul 28, 26 | ZAGO WAGNER M Officer |
— | 51.00K | — | Direct |
| Jul 28, 26 | SMITH BRANDON S Chief Operating Officer |
— | 78.00K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ECOR1 CAPITAL, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
ISAACS MICHAEL JOHN |
General Counsel | 35.74K | Sale |
KINGSTON ANNE EVANS |
Officer | 55.78K | Sale |
KINNEY GENE G PH.D. |
Chief Executive Officer | 68.79K | Conversion of Exercise of derivative security |
MALECEK MICHAEL J. |
Officer | 80.00K | Stock Award(Grant) |
NGUYEN TRAN BRYAN |
Chief Financial Officer | 40.20K | Conversion of Exercise of derivative security |
SCULLY WILLIAM P |
Beneficial Owner of more than 10% of a Class of Security | — | Purchase |
SMITH BRANDON S |
Chief Operating Officer | 52.00K | Conversion of Exercise of derivative security |
SWANSON CHAD PH.D. |
Officer | 40.73K | Conversion of Exercise of derivative security |
ZAGO WAGNER M |
Officer | 34.00K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$411.72M
Enterprise value$130.52M
Revenue (TTM)$54.53M
Gross profit$-10.42M
EBITDA$-59.04M
Net income$-43.99M
EPS (TTM)$-0.79
Free cash flow$-54.22M
Total cash$288.19M
Total debt$6.99M
Book value / share$5.54
Shares outstanding51.34M
Float34.54M
Short % of float20.05%
Dividend yield0.00%
Beta (5Y)-0.29
Valuation & profitability ratios
Trailing P/E—
Forward P/E-5.28
PEG ratio—
Price / sales—
Price / book1.45
EV / revenue2.39
EV / EBITDA-2.21
Gross margin-19.11%
Operating margin-1850.20%
Profit margin-80.68%
Return on equity-14.39%
Return on assets-10.67%
Debt / equity2.44
Current ratio25.05
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $9.68M | $135.16M | $91.37M | $53.91M | -92.8% |
| Operating revenue | $9.68M | $135.16M | $91.37M | $53.91M | -92.8% |
| Research & development | $134.85M | $222.52M | $220.57M | $135.56M | -39.4% |
| Selling, general & admin | $59.39M | $67.20M | $61.84M | $49.90M | -11.6% |
| Total operating expense | $194.24M | $289.72M | $282.41M | $185.46M | -33.0% |
| Operating income | -$184.56M | -$154.56M | -$191.04M | -$131.56M | -19.4% |
| Net interest income | $14.14M | $25.82M | $31.01M | $6.35M | -45.2% |
| Pre-tax income | -$200.83M | -$128.93M | -$160.48M | -$125.61M | -55.8% |
| Tax provision | $43.26M | -$6.62M | -$13.45M | -$8.66M | +753.5% |
| Net income | -$244.09M | -$122.31M | -$147.03M | -$116.95M | -99.6% |
| Net income to common | -$244.09M | -$122.31M | -$147.03M | -$116.95M | -99.6% |
| Basic EPS | -4.53 | -2.27 | -2.76 | -2.47 | -99.6% |
| Diluted EPS | -4.53 | -2.27 | -2.76 | -2.47 | -99.6% |
| EBIT | -$184.56M | -$154.56M | -$191.04M | -$131.56M | -19.4% |
| EBITDA | -$183.66M | -$153.67M | -$190.11M | -$130.81M | -19.5% |
| Basic shares | 53.83M | 53.77M | 53.22M | 47.37M | +0.1% |
| Diluted shares | 53.83M | 53.77M | 53.22M | 47.37M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $307.53M | $471.39M | $618.83M | $710.41M | — | -34.8% |
| Cash & short-term investments | $307.53M | $471.39M | $618.83M | $710.41M | — | -34.8% |
| Accounts receivable | — | $0 | $5.16M | $0 | $13.00K | — |
| Total current assets | $315.19M | $485.41M | $639.28M | $719.10M | — | -35.1% |
| Property, plant & equipment | $10.27M | $13.79M | $16.00M | $8.01M | — | -25.5% |
| Total assets | $326.80M | $547.11M | $696.38M | $758.03M | — | -40.3% |
| Total current liabilities | $40.84M | $48.50M | $56.89M | $50.15M | — | -15.8% |
| Total debt | $8.37M | $10.84M | $11.84M | $6.47M | — | -22.8% |
| Total liabilities | $46.33M | $60.18M | $135.02M | $135.99M | — | -23.0% |
| Retained earnings | -$1.35B | -$1.10B | -$980.03M | -$833.00M | — | -22.1% |
| Shareholder equity | $280.47M | $486.93M | $561.37M | $622.04M | — | -42.4% |
| Working capital | $274.35M | $436.91M | $582.39M | $668.95M | — | -37.2% |
| Net tangible assets | $280.47M | $486.93M | $561.37M | $622.04M | — | -42.4% |
| Shares issued | 53.83M | 53.83M | 53.68M | 52.10M | — | +0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$244.09M | -$122.31M | -$147.03M | -$116.95M | -99.6% |
| Depreciation & amortisation | $895.00K | $893.00K | $928.00K | $744.00K | +0.2% |
| Stock-based compensation | $37.64M | $45.96M | $40.91M | $31.32M | -18.1% |
| Change in working capital | -$4.17M | -$67.94M | -$20.53M | -$18.80M | +93.9% |
| Operating cash flow | -$163.58M | -$150.05M | -$133.91M | -$108.82M | -9.0% |
| Capital expenditure | -$138.00K | -$298.00K | -$2.81M | -$464.00K | +53.7% |
| Investing cash flow | -$138.00K | -$298.00K | -$2.77M | -$464.00K | +53.7% |
| Share buybacks | -$139.00K | -$353.00K | — | — | +60.6% |
| Financing cash flow | -$139.00K | $1.55M | $45.10M | $241.46M | -108.9% |
| Free cash flow | -$163.72M | -$150.35M | -$136.72M | -$109.28M | -8.9% |
| End cash position | $308.39M | $472.25M | $621.04M | $712.62M | -34.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.01M | $51.08M | $21.00K | $2.42M | $4.42M | -98.0% |
| Operating revenue | $1.01M | $51.08M | $21.00K | $2.42M | $4.42M | -98.0% |
| Research & development | $8.80M | $12.63M | $14.59M | $28.94M | $40.52M | -30.3% |
| Selling, general & admin | $10.90M | $12.67M | $12.65M | $13.24M | $15.91M | -14.0% |
| Total operating expense | $19.70M | $25.29M | $27.23M | $42.18M | $56.43M | -22.1% |
| Operating income | -$18.69M | $25.79M | -$27.21M | -$39.76M | -$52.01M | -172.5% |
| Net interest income | $2.55M | $2.42M | $2.65M | $3.35M | $3.79M | +5.7% |
| Pre-tax income | -$18.58M | $32.72M | -$21.58M | -$36.91M | -$80.97M | -156.8% |
| Tax provision | $2.00K | $1.00K | $10.00K | -$371.00K | $44.80M | +100.0% |
| Net income | -$18.58M | $32.72M | -$21.59M | -$36.54M | -$125.77M | -156.8% |
| Net income to common | -$18.58M | $32.72M | -$21.59M | -$36.54M | -$125.77M | -156.8% |
| Basic EPS | -0.36 | 0.61 | -0.40 | -0.68 | -2.34 | -159.0% |
| Diluted EPS | -0.36 | 0.60 | -0.40 | -0.68 | -2.34 | -160.0% |
| EBIT | -$18.69M | $25.79M | -$27.21M | -$39.76M | -$52.01M | -172.5% |
| EBITDA | -$18.49M | $25.98M | -$26.99M | -$39.53M | -$51.78M | -171.2% |
| Basic shares | 52.15M | 53.71M | 53.83M | 53.83M | 53.83M | -2.9% |
| Diluted shares | 52.15M | 54.11M | 53.83M | 53.83M | 53.83M | -3.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $288.19M | $329.46M | $307.53M | $330.84M | $371.44M | -12.5% |
| Cash & short-term investments | $288.19M | $329.46M | $307.53M | $330.84M | $371.44M | -12.5% |
| Total current assets | $292.01M | $339.20M | $315.19M | $339.97M | $385.48M | -13.9% |
| Property, plant & equipment | $9.22M | $9.35M | $10.27M | $11.31M | $12.25M | -1.4% |
| Total assets | $302.58M | $349.89M | $326.80M | $352.63M | $399.07M | -13.5% |
| Total current liabilities | $11.66M | $32.52M | $40.84M | $51.44M | $67.81M | -64.1% |
| Total debt | $6.99M | $7.65M | $8.37M | $9.08M | $9.78M | -8.7% |
| Total liabilities | $15.69M | $37.28M | $46.33M | $57.64M | $74.73M | -57.9% |
| Retained earnings | -$1.33B | -$1.31B | -$1.35B | -$1.32B | -$1.29B | -1.4% |
| Shareholder equity | $286.89M | $312.62M | $280.47M | $294.99M | $324.33M | -8.2% |
| Working capital | $280.36M | $306.68M | $274.35M | $288.54M | $317.67M | -8.6% |
| Net tangible assets | $286.89M | $312.62M | $280.47M | $294.99M | $324.33M | -8.2% |
| Shares issued | 51.74M | 53.08M | 53.83M | 53.83M | 53.83M | -2.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$18.58M | $32.72M | -$21.59M | -$36.54M | -$125.77M | — | -156.8% |
| Depreciation & amortisation | $197.00K | $184.00K | $218.00K | $229.00K | $225.00K | — | +7.1% |
| Stock-based compensation | $7.88M | $6.92M | $7.07M | $7.20M | $12.42M | — | +13.9% |
| Change in working capital | -$13.52M | -$6.48M | -$9.84M | -$12.17M | $21.19M | — | -108.7% |
| Operating cash flow | -$25.05M | $28.88M | -$23.31M | -$40.56M | -$46.34M | — | -186.7% |
| Capital expenditure | — | — | — | -$10.00K | -$86.00K | -$42.00K | — |
| Investing cash flow | -$652.00K | $0 | $0 | -$10.00K | -$86.00K | — | — |
| Share buybacks | -$15.57M | -$6.95M | $0 | -$17.00K | -$74.00K | — | -124.1% |
| Financing cash flow | -$15.57M | -$6.95M | $0 | -$17.00K | -$74.00K | — | -124.1% |
| Free cash flow | -$25.70M | $28.88M | -$23.31M | -$40.58M | -$46.43M | — | -189.0% |
| End cash position | $289.05M | $330.32M | $308.39M | $331.70M | $372.30M | — | -12.5% |
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
7.00
-12.7% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
16
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
7.00
0 contracts
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.38 | -0.31 | +18.4% |
| Mar 2026 | -0.31 | 0.68 | +324.0% |
| Dec 2025 | -0.46 | -0.46 | +0.7% |
| Sep 2025 | -0.54 | -0.67 | -24.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.38 | 1 | $9.58M | +296.5% |
| Next quarter | 0.74 | 1 | $21.50M | +102,281.8% |
| Current year | 0.65 | 1 | $83.16M | +758.7% |
| Next year | -1.52 | 1 | $24.38M | -70.7% |
Analyst targets & ownership
Mean target$21.40
High target$36.00
Low target$8.00
Implied upside162.25%
Analyst count5
ConsensusNONE
Strong buy / Buy2 / 1
Hold2
Sell / Strong sell0 / 1
Held by insiders22.35%
Held by institutions93.91%
Institutions holding256
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
8.44
-3.27% from price
SMA 20
8.58
-6.52% from price
SMA 50
8.86
-9.45% from price
SMA 100
9.00
-9.36% from price
SMA 200
9.31
-13.83% from price
EMA 12
8.45
-3.49% from price
EMA 26
8.66
-5.77% from price
EMA 50
8.82
-7.53% from price
RSI (14)
38.2
Neutral
MACD (12,26,9)
-0.20
Hist -0.04
ATR (14)
0.41
5.14% of price
Realised vol 30D
43.1%
Annualised
Bollinger upper
9.21
20, 2σ
Bollinger lower
7.95
20, 2σ
50 / 200 cross
Death
8.86 vs 9.31
Trend bias
Below 200
-13.83%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.01
More volatile than market
Correlation to SPY
0.28
Largely independent
Realised vol 30D
43.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-31.3%
Peak to trough
Max drawdown 5Y
-94.2%
Peak to trough
ATR 14
0.41
5.14% of price
Beta (reported)
-0.29
5Y monthly, from filing
Short interest
Shares short
8.54M
Prior 8.55M
Change vs prior
-0.0%
Shorts covering
% of float
20.05%
Heavily shorted
% of shares out
16.64%
Against total outstanding
Days to cover
25.5
Crowded exit
Float
34.54M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 8, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Feb 20, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Dec 1, 25 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Nov 7, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 7, 25 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Oct 28, 25 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Oct 7, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Sep 2, 25 | JMP Securities | MAINTAINED | Market Outperform | Market Outperform |
| Aug 28, 25 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Aug 28, 25 | Chardan Capital | MAINTAINED | Buy | Buy |
| Aug 5, 25 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Aug 5, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-02
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-05-15
Periodic Financial Reports
10-Q · 2026-05-07
Annual Report to Shareholders
ARS · 2026-03-27
Periodic Financial Reports
10-K · 2026-02-27
Corporate Changes & Voting Matters
8-K · 2026-02-19
Corporate Changes & Voting Matters
8-K · 2025-12-12
Headlines
Prothena Corp Public Ltd Insider Bought Shares Worth $857,240, According to a Recent SEC Filing
MT Newswires · 12h ago
Prothena Corp Public Ltd Insider Bought Shares Worth $889,872, According to a Recent SEC Filing
MT Newswires · 7d ago
Prothena Corp Public Ltd Insider Bought Shares Worth $843,460, According to a Recent SEC Filing
MT Newswires · 15d ago
4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day
Zacks · 16d ago
Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Business Wire · 27d ago
Real Parkinson’s Disease Hope from Jupiter Neurosciences
Exec Edge · 49d ago
KMDA or PRTA: Which Is the Better Value Stock Right Now?
Zacks · 54d ago
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus
Zacks · 60d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.